Harmony Biosciences Holdings, Inc.
HRMY • NASDAQ
Harmony Biosciences Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeffrey Dayno, with a market cap of $1.7B.
Market Cap$1.7B
Employees246.0
CEOJeffrey Dayno
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Harmony Biosciences Holdings, Inc. FAQ
Common questions about Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $226.0M.
Harmony Biosciences Holdings, Inc. has approximately 246 employees.